# Fludeoxyglucose F18

NDC: 76451-118
Generic name: Fludeoxyglucose F18
Labeler / Manufacturer: 3D Imaging Drug Design and Development LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20120102

FDA application: ANDA203778

## Active ingredients

- FLUDEOXYGLUCOSE F-18: 300 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76451-118"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76451-118
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2785ce60-86c9-42c2-ab0a-8c5d5adf60d3